In the initial experiments reviewed here, we show that atrial natriure
tic peptide (ANP) plays an important inhibitory role in the control of
sodium chloride and water intake since injections of ANP into the thi
rd ventricle (3V) caused a reduction in dehydration-induced drinking a
nd also the drinking of salt in salt-depleted rats. Attention was then
turned to the possible role of the brain ANP neurons in producing nat
riuresis which had earlier been shown to be caused by stimulations wit
hin the anterior ventral third ventricular region (AV3V), Stimulation
in this region by carbachol produced natriuresis accompanied by a dram
atic increase in plasma ANP concentrations and increased content of th
e peptide in medial basal hypothalamus (MBH), neurohypophysis (NH) and
anterior pituitary gland (AP), without alterations in the content of
ANP in lungs or atria, This suggested that the natriuresis resulting f
rom the stimulation is brought about, at least in part, by the release
of ANP from the brain, Conversely, there was a dramatic decline in pl
asma ANP at both 24 and 128 h after AV3V lesions had been placed, In v
iew of the much larger quantities of the peptide stored in the atria,
it is probable that the changes in the atrial release of the peptide w
ere the main factors altering plasma ANP, but that there was concomita
nt alteration in the release of brain ANP as well, Blood volume expans
ion (EVE) by intraatrial injection of isotonic saline in the rat is a
profound stimulus for ANP release. Lesions in the AV3V region, median
eminence, or neurohypophysectomy blocked EVE-induced release of ANP in
dicating the crucial participation of the CNS in the response of ANP a
nd natriuresis. Baroreceptor impulses from the carotid-aortic sinus re
gions and the kidney are important in the neuroendocrine control of AN
P release since deafferentation of these regions lowered basal plasma
ANP concentrations and prevented the increase after EVE. The evidence
indicates that the ANP release, in response to EVE, is mediated by aff
erent baroreceptor impulses to the AV3V, which mediates the increased
ANP release via activation of the hypothalamic ANP neuronal system, Ou
r recent data support the hypothesis that EVE causes the release of AN
P from ANPergic neurons in the hypothalamus that in turn stimulates re
lease of oxytocin from the neurohypophysis. This oxytocin acts to rele
ase ANP from the right atrium that has negative chrono-and inotropic e
ffects in the right atrium to reduce cardiac output, thereby reducing
effective circulating blood volume, Then, the released ANP circulates
to the kidneys and evokes natriuresis to return circulating blood volu
me to normal, This is further accomplished by reduction in intake of w
ater and salt mediated also by brain ANP.